These mice were crossed with MT/ret [41], MMTV-PyMT [42] and MMTV-Neu [43] transgenic mice to generate compound mice that spontaneously developed melanomas or mammary tumors, respectively, and that also expressed GFP under the control of the endogenous Nanog or Oct4 promoter. This evidence concerns the gene RET and breast cancer.